Nicholas Counsell

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications

Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting.

Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 13, 2026

Outcomes for Sinonasal Undifferentiated Carcinoma (SNUC): An International Multi-Center Retrospective Cohort Study.

Outcomes for Sinonasal Undifferentiated Carcinoma (SNUC): An International Multi-Center Retrospective Cohort Study.

Journal: Cancers
Published: December 23, 2025

Optimizing adjuvant treatment strategy in advanced clear cell endometrial cancer: systematic review and meta-analysis.

Optimizing adjuvant treatment strategy in advanced clear cell endometrial cancer: systematic review and meta-analysis.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 06, 2025

An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.

An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.

Journal: NEJM evidence
Published: June 19, 2025

An App-Based Behavioral Support Intervention Promoting Physical Activity (APPROACH) in Patients Diagnosed With Breast, Prostate, or Colorectal Cancer: Protocol for a Randomized Controlled Trial.

An App-Based Behavioral Support Intervention Promoting Physical Activity (APPROACH) in Patients Diagnosed With Breast, Prostate, or Colorectal Cancer: Protocol for a Randomized Controlled Trial.

Journal: JMIR research protocols
Published: May 07, 2025

Role of somatostatin receptor 2 (SSTR2) in pituitary adenomas.

Role of somatostatin receptor 2 (SSTR2) in pituitary adenomas.

Journal: Clinical and translational medicine
Published: April 17, 2025

Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial.

Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial.

Journal: JAMA oncology
Published: February 06, 2025

Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer.

Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer.

Journal: BMJ open
Published: January 14, 2025

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression.

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression.

Journal: Clinical and translational medicine
Published: December 10, 2024

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study.

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study.

Journal: Blood advances
Published: October 21, 2024

Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.

Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: July 24, 2024

The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK.

The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK.

Journal: Cancer medicine
Published: October 10, 2023
Showing 1-12 of 69

Last Updated: 09/26/2026